Therefore, a larger and more comprehensive multicenter study should be performed to better assess the efficacy and tumor-specific factors expected from radiation therapy, justify the possible associated risks, and evaluate the real radiation dose that is needed to eradicate Rb. The gene discussed is RB1; the disease is neoplasm.